Story Navigation
-
Access to HealthcareAccess to HealthcareCancerNovartis AccessSocial CommitmentMay 19, 2022Boosting access to cancer care where it’s needed most
Low- and middle-income countries will account for some three in four of the world’s cancer deaths within the next decade without better access to care. It’s a gap Amy Israel and her team at Novartis are trying to bridge.
Access to Healthcare -
Access to HealthcareAccess to HealthcareInfectious DiseasesMalariaMedical InnovationsTropical DiseasesApr 7, 2022Staying one step ahead of the malaria parasite
Thierry Diagana and his team are on a quest to discover new therapeutics for malaria. He believes malaria elimination is within our grasp, but emerging drug resistance could jeopardize the hard-fought progress.
Access to Healthcare -
Access to HealthcareChronic IllnessEnvironmental SustainabilityInfectious DiseasesMalariaNovartis Institutes for BioMedical ResearchApr 4, 2022Tackling the health toll of climate changeAccess to Healthcare
-
Patient PerspectivesMar 21, 2022Understanding hidradenitis suppurativa through Jasmine’s eyesPatient Perspectives
-
Access to HealthcareAccess to HealthcareCardiovascular DiseaseHeart DiseaseNovartis AccessMar 1, 2022Prioritizing the needs of patientsAccess to Healthcare
-
From Our LabsCancerClinical ResearchInnovationOncologyScientific ResearchDec 1, 2021When it comes to cancer, there’s power in a good partner
Combinations of drugs could hold the key to overcoming some of the biggest challenges in lung and other cancers.
From Our Labs -
DiscoveryBiomedical ResearchData ScienceDrug DevelopmentDrug DiscoveryEmerging TechnologyNov 15, 2021The art of drug design in a technological age
Novartis is collaborating with Microsoft to apply machine learning to medicinal chemistry — part of an effort to leverage AI to bring treatments to patients more efficiently.
Discovery -
DiscoveryBiomedical ResearchCOVID-19Drug DiscoveryNovartis Institutes for BioMedical ResearchScientific ResearchNov 10, 2021Stopping this coronavirus – and the next one
Inside the hunt for new antivirals to combat the current pandemic and to prepare for future ones.
Discovery -
DiscoveryCancerInnovationScientific ResearchOncologyNov 4, 2021Solving the puzzle of immunotherapy
From an eccentric idea to a revolution in medicine – the history of immunotherapy and a peek into its future.
Discovery -
Access to HealthcareAccess to HealthcareDisease AwarenessGenetic DiseaseLiving With DiseasePatient VoicesNov 1, 2021Breaking down barriers for patients with sickle cell disease
One patient’s story reveals the hidden obstacles to better health – and opportunities to help clear them.
Access to Healthcare -
Access to HealthcareDrug DevelopmentInnovationWorking at NovartisNov 2, 2021To make a difference, start with patients
John Tsai, Head of Global Drug Development and Chief Medical Officer, describes how he balances innovation and patient needs.
Access to Healthcare -
Access to HealthcareCancerDisease AwarenessFuture of HealthcareOncologyPatient EducationOct 25, 2021Demystifying the science of myelodysplastic syndromes
Novartis works with visual artist Noma Bar and international patient group MDS Alliance to send a message of hope to people living with myelodysplastic syndromes.
Access to Healthcare
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- …
- 30
- › Next page